These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1370105)

  • 41. Mutagens in surface waters: a review.
    Ohe T; Watanabe T; Wakabayashi K
    Mutat Res; 2004 Nov; 567(2-3):109-49. PubMed ID: 15572284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An improvement of the Ames test using a modified human liver S9 preparation.
    Hakura A; Suzuki S; Sawada S; Motooka S; Satoh T
    J Pharmacol Toxicol Methods; 2001; 46(3):169-72. PubMed ID: 12183193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
    De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
    J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotoxic bioactivation of constituents of a diesel exhaust particle extract by the human lung.
    Iba MM; Caccavale RJ
    Environ Mol Mutagen; 2013 Apr; 54(3):158-71. PubMed ID: 23400972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Participation of cytochrome P450 in mutagenic activation of the carcinogen 3'-hydroxymethyl-N,N-dimethyl-4-aminoazobenzene and its N-demethylated compounds by rat liver.
    Mori Y; Niwa T; Toyoshi K
    Mutat Res; 1983 Oct; 122(1):13-22. PubMed ID: 6413856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
    Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
    Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rat pulmonary microsomal cytochrome P-450 enzymes involved in the activation of procarcinogens.
    Shimada T; Yamazaki H; Mimura M; Guengerich FP
    Mutat Res; 1992 Dec; 284(2):233-41. PubMed ID: 1281274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induced hepatocytes as a metabolic activation system for the mouse-lymphoma assay.
    Oglesby LA; Brock KH; Moore MM
    Mutat Res; 1989 Jul; 223(3):295-302. PubMed ID: 2739685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenic potential of binary and complex mixtures using different enzyme induction systems.
    Markiewicz KV; Howie LE; Safe SH; Donnelly KC
    J Toxicol Environ Health; 1996 Apr; 47(5):443-51. PubMed ID: 8614014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF; Tang X; Edenharder R
    Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NADPH-generating system: influence on microsomal mono-oxygenase stability during incubation for the liver-microsomal assay with rat and mouse S9 fractions.
    Forti GC; Paolini M; Hrelia P; Corsi C; Biagi GL; Bronzetti G
    Mutat Res; 1984 Dec; 129(3):281-97. PubMed ID: 6392864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the in vitro mutagenicity and metabolism of dimethylnitrosamine and benzo[a]pyrene in tissues from inbred mice treated with phenobarbital, 3-methylcholanthrene or polychlorinated biphenyls.
    Hutton JJ; Meier J; Hackney C
    Mutat Res; 1979 Jan; 66(1):75-94. PubMed ID: 106274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of S9 fractions from mouse and rat with increased enzyme activities after repeated administration of cytochrome P-450 and P-448 inducers.
    Paolini M; Sapigni E; Hrelia P; Grilli S; Cantelli-Forti G
    Mutagenesis; 1988 May; 3(3):239-43. PubMed ID: 3045486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eightfold induction of nicotine elimination in perfused rat liver by pretreatment with phenobarbital.
    Rüdell U; Foth H; Kahl GF
    Biochem Biophys Res Commun; 1987 Oct; 148(1):192-8. PubMed ID: 3675573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microsomal transformation of emodin into a direct mutagen.
    Masuda T; Ueno Y
    Mutat Res; 1984 Feb; 125(2):135-44. PubMed ID: 6366529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability of drug metabolizing enzymes during the incubation conditions of the liver microsomal assay with non-induced and induced mouse liver S-9 fractions.
    Paolini M; Tonelli F; Bauer C; Corsi C; Bronzetti G
    Carcinogenesis; 1987 Sep; 8(9):1179-84. PubMed ID: 3113750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters.
    Apostolides Z; Balentine DA; Harbowy ME; Hara Y; Weisburger JH
    Mutat Res; 1997 Mar; 389(2-3):167-72. PubMed ID: 9093380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutagenicity of nitro derivatives produced by exposure of dibenzofuran to nitrogen oxides.
    Watanabe T; Hirayama T
    Mutat Res; 1992 Sep; 283(1):35-43. PubMed ID: 1380661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.